Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2003-08-01
Metadata
Show full item recordCitation
Scand. J. Immunol. 2003, 58(2):129-38Abstract
A common immunopathological hallmark of many autoimmune inflammatory diseases is a T-cell invasion and accumulation at the inflamed tissue. Although the exact molecular and microenvironmental mechanisms governing such cellular invasion and tissue retention are not known, some key immunological principles must be at work. Transforming growth factor-beta (TGF-beta) is known to modulate some of these processes including homing, cellular adhesion, chemotaxis and finally T-cell activation, differentiation and apoptosis. The chronicity of such T-cell-driven inflammation probably involves an innate immunological response leading to a T-1 (Th/Tc), T-2 or T-3 (Th/Tr) T-cell adaptive immune response. Several studies suggest that the key to T-cell final destination resides on its and the antigen-presenting cell's phenotype as well as the coreceptor expression pattern and their signalling intensity. Recent observations suggest other equally important regulatory elements of T-cell inflammatory response that are sensitive to TGF-beta modulation. These include: (i) the stage of T-cell activation/differentiation; (ii) the chemotactic/adhesion molecule expression pattern; and (iii) the conditioning at the immunological synapse determining their sensitivity to known regulators such as TGF-beta. In this article, we focus on how the phenotype of the responding T cell and the T-cell receptor (TCR)-signalling intensity could drive the given inflammatory response. In particular, we discuss how TGF-beta can influence the process of T-cell migration and activation during such site-specific inflammation.ae974a485f413a2113503eed53cd6c53
doi:10.1046/j.1365-3083.2003.01297.x
Scopus Count
Collections
Related articles
- Transforming growth factor-beta: recent advances on its role in immune tolerance.
- Authors: Kriegel MA, Li MO, Sanjabi S, Wan YY, Flavell RA
- Issue date: 2006 Apr
- Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells.
- Authors: Kosiewicz MM, Alard P
- Issue date: 2004
- The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
- Authors: Prud'homme GJ, Piccirillo CA
- Issue date: 2000 Feb
- Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.
- Authors: Wahl SM, Chen W
- Issue date: 2005
- Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.
- Authors: Alard P, Clark SL, Kosiewicz MM
- Issue date: 2003 Aug